X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
0
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
22
PharmaCompass offers a list of Lenvatinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lenvatinib manufacturer or Lenvatinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lenvatinib manufacturer or Lenvatinib supplier.
PharmaCompass also assists you with knowing the Lenvatinib API Price utilized in the formulation of products. Lenvatinib API Price is not always fixed or binding as the Lenvatinib Price is obtained through a variety of data sources. The Lenvatinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lenvatinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lenvatinib, including repackagers and relabelers. The FDA regulates Lenvatinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lenvatinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lenvatinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lenvatinib supplier is an individual or a company that provides Lenvatinib active pharmaceutical ingredient (API) or Lenvatinib finished formulations upon request. The Lenvatinib suppliers may include Lenvatinib API manufacturers, exporters, distributors and traders.
click here to find a list of Lenvatinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Lenvatinib DMF (Drug Master File) is a document detailing the whole manufacturing process of Lenvatinib active pharmaceutical ingredient (API) in detail. Different forms of Lenvatinib DMFs exist exist since differing nations have different regulations, such as Lenvatinib USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Lenvatinib DMF submitted to regulatory agencies in the US is known as a USDMF. Lenvatinib USDMF includes data on Lenvatinib's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Lenvatinib USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Lenvatinib suppliers with USDMF on PharmaCompass.
A Lenvatinib written confirmation (Lenvatinib WC) is an official document issued by a regulatory agency to a Lenvatinib manufacturer, verifying that the manufacturing facility of a Lenvatinib active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Lenvatinib APIs or Lenvatinib finished pharmaceutical products to another nation, regulatory agencies frequently require a Lenvatinib WC (written confirmation) as part of the regulatory process.
click here to find a list of Lenvatinib suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lenvatinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lenvatinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lenvatinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lenvatinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lenvatinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lenvatinib suppliers with NDC on PharmaCompass.
Lenvatinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lenvatinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lenvatinib GMP manufacturer or Lenvatinib GMP API supplier for your needs.
A Lenvatinib CoA (Certificate of Analysis) is a formal document that attests to Lenvatinib's compliance with Lenvatinib specifications and serves as a tool for batch-level quality control.
Lenvatinib CoA mostly includes findings from lab analyses of a specific batch. For each Lenvatinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lenvatinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Lenvatinib EP), Lenvatinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lenvatinib USP).
Market Place
